| ObjectiveThrough determination of two groups of patients with a diagnosis of Osteoporosis (Osteoporosis) (the control group treated with calcium he D, afar D3, the treatment group on the basis of this to add with the kidney invigorate the circulation of Chinese traditional medicine treatment) before and after treatment of the Visual analog pain rating scale (Visual analoge scale, VAS) pain scores, Oswestry disability scores and the change of clinical symptoms, a preliminary assessment of kidney invigorate the circulation of Chinese medicine in the prevention of osteoporotic spine fracture comprehensive curative effect, for clinical use of traditional Chinese medicine for the treatment of osteoporosis to offers a clear effective treatments and objective clinical basis.MethodProspective randomized controlled study was used with guangdong hospital of zhuhai orthopaedic hospital outpatient and the inpatient between January 2014 and December 2014 2014 cases of patients with osteoporosis diagnosis standard adopts the method of random divided into 2 groups, treatment group (40 cases, using the quasi kidney invigorate the circulation of Chinese traditional medicine medicinal broth, take orally twice daily, and cooperate with the oral calcium he D, daily 1 tablets, capsules, oral afar D3 2 per day; The control group,40 cases of oral calcium tablets daily he D 1 piece,2 PCS afar D3 capsules daily, observation for 3 months, before detailing each patient before the treatment age, course of the disease, bone mineral density, record lumbocrural pain VAS scores before and after the treatment for each patient and Oswestry disability rating score, comparing statistical analysis respectively, the conclusion.Result1. Baseline data:age:the treatment group was 56.40+/-5.64 years of age, and the control group was 56.50+/-5.61; Duration:the treatment group was 14.000+/-1.3228 months, control group is:14.075+/-1.2065 months; Treatment before the bone density values (Z):the treatment group was 3.0275 +/-0.29525, compared with 3.0950 0.23419 mm, waist and leg pain VAS score score before treatment:the treatment group is:7.900+/-0.77790 points, the control group as follows:7.825+/-0.78078; Oswestry disability rating score before treatment:the treatment group is:0.5185+/-0.3386, the control group is:0.5353+/-0.04356, the indicators baseline differences between the two groups (P>0.05), two groups were comparable.2. Clinical efficacy of indicators:1 month after treatment in treatment group and comparison of VAS score:5.7500+/-0.70711,6.3750 0.49029 mm, 2 months follow-up visit VAS scores are:4.2500+/-0.98058,0.98058+/-0.57957,4 months follow-up visit VAS scores are:2.7500+/-1.354018, 3.4250 1.12973 mm; For 1 month after treatment in treatment group and control group in Oswestry disability index scores are:0.3948+/-0.6325,0.4488 0.0611 mm,2 months after the Oswestry disability index scores are:0.2755 +/-0.09655,0.09655+/-0.10006,4 months after the Oswestry disability index scores are:0.1788+/-0.09801,0.09801+/-0.10991. Clinical efficacy of treatment group and control group in Oswestry disability index, effective and invalid cases were markedly improved for 27 cases (67.5%), respectively, 10 cases (25%),3 cases (7.5%) and 23 cases (57.5%),12 cases (30%),5 cases (12.5%), treatment group total effectiveness 92.5%, control group total effective rate was 87.5%, the treatment group and control group after treatment curative effect have significant difference (P<0.01).ConclusionFor patients with osteoporosis in elderly patients with osteoporosis, kidney; complications caused by osteoporosis has great influence on the quality of life of patients, decoction of Bushen Huoxue Decoction significantly in comprehensive curative effect in the treatment of osteoporosis, combined with Caltrate D, a D3 method can significantly improve the quality of life of patients. |
PDF Full Text Request